Overview
David A. Kanter is a partner at Swanson, Martin & Bell, LLP. David has spent his entire career counseling and defending chemical companies, pharmaceutical and medical device companies and other product manufacturers that face legal challenges involving complex medical and scientific issues. He primarily represents pharmaceutical companies in product liability cases and chemical companies in toxic exposure cases across the country in both putative class actions and individual or mass injury cases. Dave has a long track record of successful results in multiple state and federal courts, including defeating class certifications, winning defense verdicts on jury trials, dismissing cases on summary judgment, and has successfully challenged the admissibility of expert testimony.
- American Bar Association,
- Co-Chair, Mass Tort Litigation Subcommittee on Toxic Torts, 2005-2010
- Defense Research Institute,
- Drug and Medical Device Committee Member
- Elected to American Board of Trial Advocates
- Law Bulletin Media, “Leading Lawyers“
- Prospective Advisory Board Member, (2024-2025)
- Product Liability and Toxic Tort
- Selected by In-House Counsel as “BTI Client Service All-Star”
- Illinois Super Lawyers®
- Civil Litigation Defense
- Martindale-Hubbell® AV Rated
- “Case Studies Indicate that Tools Currently Available to Assure Quality and Integrity of Federal Government Science are Inadequate,” Society of Environmental Toxicology and Chemistry Annual Meeting, November 2017
- “Views from the Bench: A Unique Opportunity to Learn How Federal and State Judges View Evidence and Arguments Specifically in the Medical Malpractice Context,” ACI Medical Malpractice Catastrophic Injuries Seminar, March 2016
- “Hazard vs. Risk; Methods of Product Deselection and the Law,” Society for Risk Analysis Annual Meeting, December 2014
- “Mass Tort Practice and Product Liability,” Northwestern University School of Law, October 2014
- “Chemical Products and Toxic Torts: From Crises to Mass Litigation: Starting Smart and Finishing Strong,” ABA Section of Litigation Products Liability and Mass Torts Committees Regional CLE Workshop, October 2010
- “Biomonitoring, Toxicogenomics and Other Emerging Tools Used to Analyze Medical Causation,” ABA Section of Litigation Products Liability and Mass Torts Committees Regional CLE Workshop, September 2009
- “New Ways to Daubert Challenge Experts: Medical Causation Meets Evidence-Based Medicine,” American Bar Association Section of Litigation, Environmental, Products Liability and Mass Torts Committees Seminar, January 2005
